Induction of apoptosis without differentiation by retinoic acid in PLB- 985 cells requires the activation of both RAR and RXR

Blood

Volumn 90, Issue 9, 1997, Pages 3345-3355

  Monczak, Yury ^a   Trudel, Michel ^a   Lamph, William W ^a   Miller Jr , Wilson H ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; DIMETHYL SULFOXIDE; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; MICROSOMAL AMINOPEPTIDASE; MYELOBLASTIN; PROTEIN BCL 2; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; RETINOIC ACID; RETINOIC ACID RECEPTOR; RETINOID X RECEPTOR;

APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; PRIORITY JOURNAL; TRANSCRIPTION REGULATION;

EID: 0030869788     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v90.9.3345     Document Type: Article

References (75)

1. Keaveney M, Stunnenberg HG: Retinoic acid receptors, in Baeuerle PA (ed): Inducible Gene Expression. Boston, MA, Birkhäuser, 1995, p 187
2. Lanotte M, Martin-Thouvenin V, Najman S, Ballerini P, Valensi F, Bergen R: NB4, a maturation inducible cell line with t(15;17) marker isolated from a human acute promyelocytic leukemia (M3). Blood 77:1080, 1991
3. Degos L, Dombret H, Chomienne C, Daniel MT, Miclea JM, Chastang C, Castaigne S, Fenaux P: All-trans-retinoic acid as a differentiating agent in the treatment of acute promyelocytic leukemia [review]. Blood 85:2643, 1995
4. Delia D, Aiello A, Formelli F, Fontanella E, Costa A, Miyashita T, Reed JC, Pierotti MA: Regulation of apoptosis induced by the retinoid N-(4-hydroxyphenyl) retinamide and effect of deregulated bcl-2. Blood 85:359, 1995
5. Nagy L, Thomazy VA, Shipley GL, Fesus L, Lamph W, Heyman RA, Chandraratna RA, Davies PJ: Activation of retinoid X receptors induces apoptosis in HL-60 cell lines. Mol Cell Biol 15:3540, 1995
6. Grignani F, Ferrucci PF, Testa U, Talamo G, Fagioli M, Alcalay M, Mencarelli A, Peschle C, Nicoletti I, Pelicci PG: The acute promyelocytic leukemia-specific PML-RARα fusion protein inhibits differentiation and promotes survival of myeloid precursor cells. Cell 74:423, 1993
7. Grignani F, Testa U, Fagioli M, Barberi T, Masciulli R, Mariani G, Peschle C, Pelicci P: Promyelocytic leukemia-specific PML-retinoic acid α receptor fusion protein interferes with erythroid differentiation of human erythroleukemia K562 cells. Cancer Res 55:440, 1995
8. He L-Z, Tribioli C, Rivi R, Peruzzi D, Pelicci PG, Soares V, Cattoretti G, Pandolfi PP: Acute leukemia with promyelocytic features in PML/RARα transgenic mice. Proc Natl Acad Sci USA 94:5302, 1997
9. Brown D, Kogan S, Lagasse E, Weissman I, Alcalay M, Pelicci PG, Atwater S, Bishop JM: A PML/RARα transgene initiates murine acute promyelocytic leukemia. Proc Natl Acad Sci USA 94:2551, 1997
10. Kakizuka A, Miller WH Jr. Umesono K, Warrell RP Jr, Frankel SR, Murty VV, Dmitrovsky E, Evans RM: Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RARα with a novel putative transcription factor, PML. Cell 66:663, 1991
11. de The H, Lavau C, Marchio A, Chomienne C, Degos L, Dejean A: The PML-RARα fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR. Cell 66:675, 1991
12. Castaigne S, Chomienne C, Daniel MT, Berger R, Fenaux P, Degos L: All-trans-retinoic acid as a differentiation therapy for acute promyelocytic leukemia. I. Clinical results. Blood 76:1704, 1990
13. Chomienne C, Ballerini P, Balitrand N, Daniel MT, Fenaux P, Castaigne S, Degos L: All-trans-retinoic acid in acute promyelocytic leukemias, II. In vitro studies: Structure-function relationship. Blood 76:1710, 1990
14. Warrell RP Jr, Frankel SR, Miller WH Jr, Scheinberg DA, Itri LM, Hittelman WN, Vyas R, Andreeff M, Tafuri A, Jakubowski A, Gabrilove J, Gordon MS, Dmitrovsky E: Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid). N Engl J Med 324:1385, 1991
15. Raelson JV, Nervi C, Rosenauer A, Benedetti L, Monczak Y, Pearson M, Pelicci PG, Miller WH Jr: The PML/RARα oncoprotein is a direct molecular target of retinoic acid in acute promyelocytic leukemia cells. Blood 88:2826, 1996
16. Yoshida H, Kitamura K, Tanaka K, Omura S, Miyazaki T, Hachiya T, Ohno R, Naoe T: Accelerated degradation of PML-retinoic acid receptor α (PML-RARA) oncoprotein by all-trans-retinoic acid in acute promyelocytic leukemia: possible role of the proteasome pathway. Cancer Res 56:2945, 1996
17. Collins SJ, Robertson KA, Mueller L: Retinoic acid-induced granulocytic differentiation of HL-60 myeloid leukemia cells is mediated directly through the retinoic acid receptor (RAR-α). Mol Cell Biol 10:2154, 1990
18. Gajewski TF, Thompson CB: Apoptosis meets signal transduction: elimination of a BAD influence. Cell 87:589, 1996
19. Korsmeyer SJ: Bcl-2 initiates a new category of oncogenes: regulators of cell death. Blood 80:879, 1992
20. Williams GT: Programmed cell death: Apoptosis and oncogenesis. Cell 65:1097, 1991
21. Hayman RA, Mangelsdorf DJ, Dyck JA, Stein RB, Eichele G, Evans RM, Thaller C: 9-cis-retinoic acid is a high affinity ligand for the retinoid X receptor. Cell 68:397, 1992
22. Levin AA, Sturzenbecker LJ, Kazmer S, Bosakowski T, Huselton C, Allenby G, Speck J, Kratzeisen C, Rosenberger M, Lovey A, Grippo JF: 9-cis-retinoic acid stereoisomer binds and activates the nuclear receptor RXRα. Nature 355:359, 1992
23. Hashimoto Y, Kagechika H, Shudo K: Expression of retinoic acid receptor genes and ligand-binding selectivity of retinoic acid receptors. Biochem Biophys Res Commun 166:1300, 1990
24. Mehta K, McQueen T, Neamati N, Collins S, Andreeff M: Activation of retinoid receptors RARα and RXRα induces differentiation and apoptosis, respectively, in HL-60 cells. Cell Growth Diff 7:179, 1996
25. Tucker KA, Lilly MB, Heck L, Rado TA: Characterization of a new human diploid myeloid leukemia cell line (PLB-985) with granulocytic and monocytic differentiating capacity. Blood 70:372, 1987
26. Sambrook J, Fritsch EF, Maniatis T: Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, NY, Cold Spring Harbor Laboratory, 1989
27. Rosenauer A, Raelson JV, Nervi C, Eydoux P, DeBlasio A, Miller WH Jr: Alterations in expression, binding to ligand and DNA, and transcriptional activity of rearranged and wildtype retinoid receptors in retinoid-resistant acute promyelocytic leukemia cell lines. Blood 88:2671, 1996
28. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156, 1987
29. Singh L, Jones KW: The use of heparin as a simple cost-effective means of controlling background in nucleic acid hybridization procedures. Nucleic Acids Res 12:5627, 1984
30. Shao W, Benedetti L, Lamph WW, Nervi C, Miller WHJ: A retinoid-resistant APL subclone expresses a dominant negative PML-RARα mutation. Blood 89:4282, 1997
31. Cleary ML, Sklar J: Nucleotide sequence of a t(14;18) chromosomal breakpoint in follicular lymphoma and demonstration of a breakpoint-cluster region near a transcriptionally active locus on chromosome 18. Proc Natl Acad Sci USA 82:7439, 1985
32. Boise LH, Gonzalez-Garcia M, Postema CE, Ding L, Lindsten T, Turka LA, Mao X, Nunez G, Thompson CB: Bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 74:597, 1993
33. Wang L, Miura M, Bergeron L, Zhu H, Yuan J: Ich-1, an Ice/ced-3-related gene, encodes both positive and negative regulators of programmed cell death. Cell 78:739, 1994
34. Oltvai ZN, Milliman CL, Korsmeyer SJ: Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74:609, 1993
35. Takayama S, Sato T, Krajewski S, Kockel K, Irie S, Millan JA, Reed JC: Cloning and functional analysis of BAG-1: A novel bcl-2 binding protein with anti-cell death activity. Cell 80:279, 1995
36. Kiefer MC, Brauer MJ, Powers VC, Wu JJ, Umansky SR, Tomei LD, Barr PJ: Modulation of apoptosis by the widely distributed Bcl-2 homologue Bak. Nature 374:736, 1995
37. Labbaye C, Zhang J, Lanotte M, Miller WH Jr, Cayre YE: Regulation of myeloblastin mRNA expression in myeloid leukemia cells treated with all-trans-retinoic acid. Blood 81:475, 1993
38. Bruel A, Benoit G, De Nay D, Brown S, Lanotte M: Distinct apoptotic responses in maturation sensitive and resistant t(15;17) acute promyelocytic leukemia NB4 cells. 9-cis-retinoic acid induces apoptosis independent of maturation and Bcl-2 expression. Leukemia 9:1173, 1995
39. Giguère V, Ong ES, Segui P, Evans RM: Identification of a receptor for the morphogen retinoic acid. Nature 330:624, 1987
40. Mangelsdorf DJ, Evans RM: The RXR heterodimers and orphan receptors [review]. Cell 83:841, 1995
41. Kontani K, Nishina H, Ohoka Y, Takahashi K, Katada T: NAD glycohydrolase specifically induced by retinoic acid in human leukemic HL-60 cells. J Biol Chem 268:16895, 1993
42. Drach J, Zhao S, Malavasi F, Mehta K: Rapid induction of CD38 antigen on myeloid leukemia cells by all-trans-retinoid acid. Biochem Biophys Res Commun 195:545, 1993
43. Drach J, McQueen T, Engel H, Andreeff M, Robertson KA, Collins SJ, Malavasi F, Mehta K: Retinoic acid-induced expression of CD38 antigen in myeloid cells is mediated through retinoic acid receptor-α. Cancer Res 54:1746, 1994
44. Perkins SL, Link DC, Kling S, Ley TJ, Teitelbaum SL: 1,25-Dihydroxyvitamin D3 induces monocytic differentiation of the PLB-985 leukemic line and promotes c-fgr mRNA expression. J Leukoc Biol 50:427, 1991
45. Wyllie AH: Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature 284:555, 1980
46. Bories D, Raynal M, Solomon DH, Darzynkiewicz Z, Cayre YE: Down-regulation of a serine protease myeloblastin causes growth arrest and differentiation of promyelocytic leukemia cells. Cell 59:959, 1989
47. Murtaugh MP, Arend WP, Davies PJ: Induction of tissue transglutaminase in human peripheral blood monocytes. J Exp Med 159:114, 1984
48. Davies PJA, Murtaugh MP, Moore WT, Johnson GS, Lucas D: Retinoic acid-induced expression of tissue transglutaminase in human promyelocytic leukemia (HL-60). J Biol Chem 260:5166, 1985
49. Benedetti L, Grignani F, Scicchitano BM, Jetten AM, Diverio D, Lo Coco F, Avvisati G, Gambacorti-Passerini C, Adamo S, Levin AA, Pelicci G, Nervi C: Retinoid-induced differentiation of acute promyelocytic leukemia involves PML-RARα-mediated increase of type II transglutaminase. Blood 87:1939, 1996
50. Mitra RS, Wrone-Smith T, Simonian P, Foreman KE, Nunez G, Nickoloff BJ: Apoptosis in keratinocytes is not dependent on induction of differentiation. Lab Invest 76:99, 1997
51. 1 and S phases of the cell cycle without growth arrest or stabilization of wild-type p53. Mol Cell Biol 14:4183, 1994
52. Lindenboim L, Diamond R, Rothenberg E, Stein R: Apoptosis induced by serum deprivation of PC12 cells is not preceded by growth arrest and can occur at each phase of the cell cycle. Cancer Res 55:1242, 1995
53. Reed JC: Bcl-2 and the regulation of programmed cell death. J Cell Biol 124:1, 1994
54. Hockenbery DM, Nunez G, Milliman C, Schriber RD, Korsmeyer SJ: Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 348:334, 1990
55. Sentman CL, Shutter JR, Hockenbery D, Kanagawa O, Korsmeyer SJ: Bcl-2 inhibits multiple forms of apoptosis but not negative selective in thymocytes. Cell 67:879, 1991
56. Carson WE, Haldar S, Baiocchi RA, Croce CM, Caligiuri MA: The c-kit ligand suppresses apoptosis of natural killer cells through the upregulation of bcl-2. Proc Natl Acad Sci USA 91:7553, 1994
57. Berchem GJ, Bosseler MM, Sugars LY, Voeller HJ, Zeitlin S, Gelmann EP: Androgens induce resistance to bcl-2-mediated apoptosis in LNCaP prostate cancer cells. Cancer Res 55:735, 1995
58. Delia D, Aiello A, Soligo D, Fontanella E, Melani C, Pezzella F, Pierotti MA, Delia Porta G: bcl-2 Proto-oncogene expression in normal and neoplastic human myeloid cells. Blood 79:1291, 1992
59. Park JR, Robertson K, Hickstein DD, Tsai S, Hockenbery DM, Collins SJ: Dysregulated bcl-2 expression inhibits apoptosis but not differentiation of retinoic acid-induced HL-60 granulocytes. Blood 84:440, 1994
60. Yang E, Korsmeyer SJ: Molecular thanatopsis: a discourse on the BCL2 family and cell death. Blood 88:386, 1996
61. Haldar S, Jena N, Croce CM: Inactivation of Bcl-2 by phosphorylation. Proc Natl Acad Sci USA 92:4507, 1995
62. L. Cell 87:619, 1996
63. Wang H-G, Rapp UR, Reed JC: Bcl-2 targets the protein kinase raf-1 to mitochondria. Cell 87:629, 1996
64. Armstrong RC, Aja R, Xiang J, Gaur S, Krebs JF, Hoang K, Bai X, Korsmeyer SJ, Karanewsky DS, Fritz LC, Tomaselli KJ: Fas-induced activation of the cell death-related protease CPP32 is inhibited by Bcl-2 and by ICE family protease inhibitors. J Biol Chem 271:16850, 1996
65. L inhibits Ara-C-induced CPP32/Yama protease activity and apoptosis of human acute myelogenous leukemia HL-60 cells. Cancer Res 56:4743, 1996
66. Monney L, Otter I, Olivier R, Ravn U, Mirzasaleh H, Fellay I, Poirier GG, Borner C: Bcl-2 overexpression blocks activation of the death protease CPP32/Yama/Apopain. Biochem Biophys Res Commun 221:340, 1996
67. Shimizu S, Eguchi Y, Kamiike W, Matsuda H, Tsudjimoto Y: Bcl-2 expression prevents activation of the ICE protease cascade. Oncogene 12:2251, 1996
68. L function upstream of the CED-3-like apoptotic proteases. J Biol Chem 271:4573, 1996
69. Gebert JF, Moghal N, Frangioni JV, Sugarbaker DJ, Neel BG: High frequency of retinoic acid receptor-β abnormalities in human lung cancer. Oncogene 6:1859, 1991
70. Nervi C, Vollberg TM, George MD, Zelent A, Chambon P, Jetten AM: Expression of nuclear retinoic acid receptors in normal tracheobronchial cells and in lung carcinoma cells. Exp Cell Res 195:163, 1991
71. Houle B, Leduc J, Bradley WEG: Implication of RARβ in epidermoid (squamous) lung cancer. Genes Chromosomes Cancer 3:358, 1991
72. Houle B, Rochette-Egly C, Bradley WEC: Tumor-suppressive effect of the retinoic acid receptor-β in human epidermoid lung cancer cells. Proc Natl Acad SCi USA 90:985, 1993
73. Lotan R, Xu X-C, Lippman SM, Ro JY, Lee JS, Lee JJ, Hong WK: Suppression of retinoic acid receptor-β in premalignant oral lesions and its up-regulation by isotretinoin. N Engl J Med 332:1405, 1995
74. Seewaldt VL, Johnson BS, Parker MB, Collins SJ, Swisshelm K: Expression of retinoic acid receptor beta mediates retinoic acid-induced growth arrest and apoptosis in breast cancer cells. Cell Growth Diff 6:1077, 1995
75. Gianni M, Terao M, Zanotta S, Barbui T, Rambaldi A, Garattini E: Retinoic acid and granulocyte colony-stimulating factor synergistically induce leukocyte alkaline phosphatase in acute promyelocytic leukemia cells. Blood 83:1909, 1994